Editor’s Statement The observation that heparin-binding growth factor/prostatropin can counteract the inhibitory effect of transforming growth factor beta in prostate epithelial cells may help explain how some cancers avoid the action of growth inhibitors and provides a model for studying how inhibitory peptides overcome the stimulatory signals generated by growth factors.
Summary
Normal rat prostate epithelial cell growth requires both epidermal growth factor and heparin-binding growth factor/prostatropin. In contrast, epithelial cells derived from the transplantable Dunning R3327H rat tumor require either epidermal growth factor or heparin-binding growth factor/prostatropin. Transforming growth factor type beta inhibited normal epithelial cell growth. Transforming growth factor beta inhibited epidermal growth factor-dependent growth of tumor epithelial cells, independent of epidermal growth factor concentrations. Transforming growth factor beta increased the effective dose of heparin-binding growth factor type 1 required to support tumor epithelial cell growth by 10-fold but saturating levels of heparin-binding growth factor type 1 (290 pM) completely attenuated the inhibitory effect of transforming growth factor beta. These results suggest that prostate tumor epithelial cells may escape the inhibitory effect of transforming growth factor beta as a consequence of alteration of the concurrent requirement for both epidermal growth factor (or homologues) and heparin-binding growth factors.
Article PDF
Avoid common mistakes on your manuscript.
References
McKeehan, W. L.; Adams, P. S.; Rosser, M. P. Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen on normal rat prostate epithelial cells in serum-free, primary cell culture. Cancer Res. 44:1998–2010; 1984.
McKeehan, W. L.; Adams, P. S.; Fast D. Different hormonal requirements for androgen-independent growth of normal and tumor epithelial cells from rat prostate. In Vitro 23:147–152; 1987.
Crabb, J. W.; Armes, L. G.; Carr, S. A., et al. The complete primary structure of prostatropin, a prostate epithelial cell growth factor. Biochemistry 25:4988–4993; 1986.
McKeehan, W. L.; Crabb, J. W. Isolation and characterization of different molecular and chromatographic forms of heparin-binding growth factor-nutrient interactions. Anal. Biochem. 164:563–569; 1987.
Jaye, M.; Howk, R.; Burgess, W., et al. Human endothelial cell growth factor: cloning, nucleotide sequence and chromosome localization. Science 233:541–545; 1986.
Abraham, J. A.; Mergia, A.; Whang, J. L., et al. Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 233:545–548; 1986.
Masui, T.; Wakefield, L. M.; Lechner, J. F., et al. Type β transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc. Natl. Acad. Sci. USA 83:2438–2442; 1986.
Shipley, G. D.; Pittelkow, M. R.; Wille, J. J., et al. Reversible inhibition of normal human prokeratinocyte proliferation by type β transforming growth factor-growth inhibitor in serumfree medium. Cancer Res. 46:2068–2071; 1986.
Hayashi, I.; Carr, B. I. DNA synthesis in rat hepatocytes: inhibition by a platelet factor and stimulation by an endogenous factor. J. Cell. Physiol. 125:82–90; 1985.
McMahon, J. B.; Richards, W. I.; delCampo, A. A., et al. Differential effects of transforming growth factor-β or proliferation of normal and malignant rat liver epithelial cells. Cancer Res. 46:4665–4671; 1986.
Lechner, J. F.; McClendon, I. A.; LaVeck, M. A., et al. Differential control by platelet factors of squamous differentiation in normal and malignant human bronchial epithelial cell Cancer Res. 43:5915–5921; 1983.
McKeehan, W. L.; McKeehan, K. A. Kinetic analysis of growth factor-nutrient interactions. Methods Enzyma 147:392–399; 1987.
Takehara, K.; LeRoy, E. C.; Grotendorst, G. R. TGF-β inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression. Cell 49:415–422; 1987.
Author information
Authors and Affiliations
Additional information
This work was supported by NCI Grant CA37589.
Rights and permissions
About this article
Cite this article
Mc Keehan, W.L., Adams, P.S. Heparin-binding growth factor/prostatropin attenuates inhibition of rat prostate tumor epithelial cell growth by transforming growth factor type beta. In Vitro Cell Dev Biol 24, 243–246 (1988). https://doi.org/10.1007/BF02623554
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02623554